Two Global Leaders in Site Enablement Technology Respond to Research Site Demand for End-to-End Solutions to Increase Efficiencies Across All Trials

New AI-Driven Platform to Transform Clinical Outcomes Assessment: COA-AI Software Merges AI Efficiency with Researcher Expertise

CEBIS International Expands Its Comprehensive Preclinical and Clinical Trials Services in 3 Continents

Quality Cancer Care Alliance’s Nationwide Network of Independent Community Oncology Practices Welcomes Comprehensive Hematology Oncology, LLC, With Eight Locations Serving St. Petersburg-Tampa Bay Communities

Florence Healthcare, the leading provider of Site Enablement Platforms for clinical trials, announced today that it has acquired VersaTrial, a cutting-edge clinical trial solutions provider.

Tampa-based site expands study capabilities and patient comfort

The company plans to leverage its platform technology to improve access and quality to medical EEG testing and to enable and improve adjacent biomedical research and clinical trials.

Revolutionizing Clinical Trials: Site Enablement League Unites Industry Leaders to Accelerate Cures and Optimize Site Experience

With multiple locations in Washington and Idaho, Cancer Care Northwest Expands Its Ability to Deliver Best Practices to Those Communities

Multidisciplinary, Independent Community Oncology & Hematology Center, Cancer Care Specialists of Reno, Nevada, adds to the Alliance's Ever-Growing National Footprint

Clinical investigator and regenerative medicine pioneer Don Buford, MD, is leading the charge to bring the latest advances in mechanobiology and regenerative medicine to 32.5 million knee arthritis sufferers across the United States in a National Institutes of Health-funded study aimed at reducing opioids and surgery.

New multiyear collaboration between Florence Healthcare and IQVIA to ensure research sites participating in IQVIA studies have access to best-in-class site enablement technology to streamline operations and power remote connectivity.

Clinical Research Division to Offer Full-Service Support, Removing Barriers to Kidney Care Innovation by Providing Access to Large Patient Populations, Trial-Ready Sites, Principal Investigators

Democratizes access to clinical research in Africa by diversifying participant cohorts and shortening drug development timelines

A new venture from the National Cancer Care Alliance (NCCA) and Quality Cancer Care Alliance (QCCA)

Patients from Montgomery, Berks, and Chester Counties will now have access to clinical trials managed by Labcorp

LTO Network announces that through its collaboration with integrator Sphereon, it will host the world's next generation of eClinical data. Triall will integrate its blockchain APIs with the eClinical solutions of CDS, realizing the world's first end-to-end eClinical platform powered by blockchain.

Expanding CLIA-certified Contract Research and Clinical Diagnostics Laboratory Secures CAP Approval

Florence, a global digital clinical research platform that connects clinical trial sponsors and study sites, launches a complementary training and certification program for clinical research and clinical operations professionals.

The company aims to advance fast and effective development of an at-home neuromodulation device for Major Depressive Disorder treatment.

Activ-2 trial provides opportunity to Miami dade County residents to participate in clinical research programs for COVID-19 with the newest medications through a private public partnership

Providing oncology drug developers with the successful delivery of early phase oncology studies

As advocates of diverse and inclusive clinical trials, patient engagement agency COUCH Health is calling on the industry take action to make clinical research more inclusive and representative of all populations. Demand Diversity has launched with the aim to raise awareness of the lack of diversity in clinical research and make change happen.

New eISF Standard Reference Model Promises to Strengthen Collaboration Among Stakeholders in Clinical Trial Life cycle.

Surge of Research Organizations Investing in Florence Shows New Wave of Site Leadership in Streamlining Study Operations

Celebrating success across life sciences

CEO and Founder of Neurovations Honored as Patient Champion

This content has been prepared exclusively for organizations that are involved in clinical research and for clinical research professionals, as CRAC has launched the first and only certified Canadian research designation "Clinical Research Professional of Canada (CRPC)®".

R&D Executive Joins as Company Prepares for Key Industry Summit

Florence today announced its membership in the Avoca Quality Consortium® (AQC) to drive technology adoption and standardization in order to reduce drug costs and development time.

Lotus Clinical Research Announces the Addition of Lee Simon, MD as Principal Advisor, Osteoarthritis Research and Allan Green, MD, PhD, JD as Medical Imaging and Research Advisor

Neil Singla, Chief Executive Officer of Lotus Clinical Research, Chaired the fourth annual American Pain Society Conference on Analgesic Trials (APS-CAT)

Ripple releases new Web to Lead feature in partnership with BrainsCAN, a neuroscience research initiative located at Western University

The first 110-module clinical research training course offered online for physicians, nurses and science degree holders. Over 1,000 CRAs, CRCs, CRMs, and PIs trained since 2014. CCRP is specialized in training physicians and healthcare professionals looking to transition and/or be promoted in the clinical research field. Professionals can complete the in-depth, 110-module training online within 30 days.

Patti Glaza of Invest Detroit joins Ripple Science Board of Directors

Application of Real-World Patient Data Radically Enhances Volunteer Commitment

Lotus Clinical Research LLC receives private equity backing; expands team with Jeffrey Kinell and Kurt Brykman joining board of directors

Society of Clinical Research Associates aims to help clinical investigators and researchers boost their skills

Lotus Clinical Research Presented at Pain Therapeutics in San Francisco on Development of Long-Acting Local Anesthetics